Advanced Thyroid Cancer Frontiers II: TKI Treatment When Do We Start?
Sunday, May 10, 2020
12:15 PM – 12:30 PM
Participants should be aware of the following financial/non-financial relationships: Ashish Chintakuntlawar, PhD, MBBS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Determine first line kinase inhibitor therapy options for advanced thyroid cancer
Review adverse event profile of kinase inhibitor therapy
Identify factors important in determining initiation of MKI therapy